The store will not work correctly when cookies are disabled.
10-chloro-7H-benzimidazo[2,1-a]benzo[de]Isoquinolin-7-one
ID: ALA4536502
Cas Number: 23982-76-5
PubChem CID: 1778614
Product Number: C286919, Order Now?
Max Phase: Preclinical
Molecular Formula: C18H9ClN2O
Molecular Weight: 304.74
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1c2cccc3cccc(c32)c2nc3ccc(Cl)cc3n12
Standard InChI: InChI=1S/C18H9ClN2O/c19-11-7-8-14-15(9-11)21-17(20-14)12-5-1-3-10-4-2-6-13(16(10)12)18(21)22/h1-9H
Standard InChI Key: ZJESJVGSDQOZAT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 26 0 0 0 0 0 0 0 0999 V2000
22.6002 -12.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3080 -11.9795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0123 -12.3909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7227 -11.9799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7203 -11.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6002 -10.7473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3073 -11.1605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0144 -10.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0199 -9.9392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3123 -9.5237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6039 -9.9323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8908 -11.9813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8863 -11.1601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1037 -10.9118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1109 -12.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6244 -11.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8104 -11.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4819 -12.4198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9694 -13.0830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7816 -12.9905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6014 -13.2113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6436 -13.8365 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13 6 1 0
12 1 1 0
1 2 1 0
7 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 8 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 6 2 0
12 13 1 0
13 14 2 0
14 16 1 0
15 12 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
1 21 2 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.74 | Molecular Weight (Monoisotopic): 304.0403 | AlogP: 4.25 | #Rotatable Bonds: ┄ |
Polar Surface Area: 34.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.08 | CX LogD: 4.08 |
Aromatic Rings: 5 | Heavy Atoms: 22 | QED Weighted: 0.43 | Np Likeness Score: -1.01 |
References
1. Dolciami D, Ballarotto M, Gargaro M, López-Cara LC, Fallarino F, Macchiarulo A.. (2020) Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs)., 185 [PMID:31727470] [10.1016/j.ejmech.2019.111842] |